Quentin Mark Anstee PhD, MRCP, FRCP

Prof Quentin Mark Anstee is Chair of Experimental Hepatology and Dean of Research & Innovation for the Faculty of Medical Sciences. A practicing clinician, he is also an Honorary Consultant Hepatologist in the Liver Unit at the Freeman Hospital, Newcastle.

Quentin's translational research has extended from the bench to the bedside with a particular focus on the pathogenesis, diagnosis, and treatment of Non-Alcoholic Fatty Liver Disease & Non-Alcoholic Steatohepatitis (NAFLD/NASH), including the identification of genetic and epigenetic modifiers of Hepatic Fibrosis progression and Hepatocellular Carcinoma (HCC) risk. He is actively involved in biomarker discovery projects that will assist in the diagnosis and risk-stratification of patients with NAFLD and serves as the Chief Investigator of several ongoing clinical trials examining new medical therapies for NAFLD.